Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Diatrizoic acid
Drug ID BADD_D00647
Description A commonly used x-ray contrast medium. As diatrizoate meglumine and as Diatrizoate sodium, it is used for gastrointestinal studies, angiography, and urography.
Indications and Usage Used, alone or in combination, for a wide variety of diagnostic imaging methods, including angiography, urography, cholangiography, computed tomography, hysterosalpingography, and retrograde pyelography. It can be used for imaging the gastrointestinal tract in patients allergic to barium.
Marketing Status approved; vet_approved
ATC Code V08AA01
DrugBank ID DB00271
KEGG ID D02240
MeSH ID D003973
PubChem ID 2140
TTD Drug ID D0T9DT
NDC Product Code Not Available
UNII 5UVC90J1LK
Synonyms Diatrizoate | Benzoic acid, 3,5-bis(acetylamino)-2,4,6-triiodo- | Hypaque | Diatrizoic Acid | Urothrast | Urotrast | Urogranoic Acid | Sodium Diatrizoate | Diatrizoate, Sodium | Diatrizoate Sodium | Sodium-Magnesium Diatrizoate | Diatrizoate, Sodium-Magnesium | Amidotrezoate | Amidotrizoate | Hypaque 50
Chemical Information
Molecular Formula C11H9I3N2O4
CAS Registry Number 117-96-4
SMILES CC(=O)NC1=C(C(=C(C(=C1I)C(=O)O)I)NC(=O)C)I
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Rash erythematous23.03.13.029--Not Available
Rash papular23.03.13.017--Not Available
Renal failure20.01.03.005--Not Available
Renal tubular necrosis20.01.07.003--Not Available
Respiratory arrest22.02.01.009--Not Available
Respiratory disorder22.02.07.002--Not Available
Respiratory distress22.02.01.012--Not Available
Retching07.01.07.002--Not Available
Retroperitoneal haemorrhage12.01.17.018; 24.07.01.017; 07.07.02.002--
Rhinitis22.07.03.006; 11.01.13.004--
Seizure17.12.03.001--
Sensory loss17.02.07.007--Not Available
Shock24.06.02.002--Not Available
Sinus arrest02.03.03.007--Not Available
Sinus bradycardia02.03.03.009--
Skin exfoliation23.03.07.003--Not Available
Skin necrosis23.03.03.011--Not Available
Sneezing22.12.03.024--
Speech disorder22.12.03.027; 19.19.02.002; 17.02.08.003--Not Available
Spinal cord injury17.10.04.001; 12.01.13.002--Not Available
Stridor22.04.02.003--
Stupor19.02.05.004; 17.02.04.007--Not Available
Swelling08.01.03.015--Not Available
Tachycardia02.03.02.007--Not Available
Tachypnoea22.02.01.014--Not Available
Throat irritation22.12.03.029; 07.05.05.037--Not Available
Thrombocytopenia01.08.01.002--Not Available
Thrombophlebitis24.01.02.001--Not Available
Thrombosis24.01.01.006--Not Available
Tongue oedema23.04.01.009; 10.01.05.008; 07.14.02.007--Not Available
The 5th Page    First    Pre   5 6    Next   Last    Total 6 Pages